Novartis releases study results on oral calcitonin for treatment of osteoarthritis: Unigene Laboratories

Links shared publicly online about this topic.

783
total visits

Novartis releases study results on oral calcitonin for treatment of osteoarthritis: Unigene Laboratories

Unigene Laboratories, Inc. announced today that Novartis has released information on the first of two studies on oral calcitonin for the treatment of osteoarthritis conducted by its license partner Nordic Bioscience. The recently completed Study 2301, which assesses the safety and efficacy of oral calcitonin in the treatment of knee osteoarthritis, had three co-primary endpoints.

View full resource at news-medical.net

Tags: Knee Pain, Osteoarthritis, Osteoporosis, Novartis, News, Safety